MedTrace Logo

Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking.

NCT05694754 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2023-01-23

No results posted yet for this study

Summary

This study evaluates de efficacy of Theta Burst Transcranial Magnetic Stimulation (TMS) applied on the left dorsolateral prefrontal cortex in patients with Major Depressive disorder and tobacco consumption.

Conditions

Interventions

DEVICE

Theta Burst Transcranial Magnetic Stimulation

Magventure MagPro R30 stimulation Device, MCF-B70 stimulation Coill

Sponsors & Collaborators

  • Dr. Julian Reyes López

    lead OTHER

Principal Investigators

  • Julian V. Reyes López, PhD · Universidad Autónoma de Querétaro

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-01
Primary Completion
2022-12-01
Completion
2023-01-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05694754 on ClinicalTrials.gov